Mohsen Moghadami

InstitutionShiraz university of medical sciences
AddressShiraz
Iran
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 16 Covid-19 publications, with a maximum of 3 publications in May 2020 and June 2020
    All Publications
    Bar chart showing 45 publications over 13 distinct years, with a maximum of 11 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ranjbar K, Moghadami M, Mirahmadizadeh A, Fallahi MJ, Khaloo V, Shahriarirad R, Erfani A, Khodamoradi Z, Saadi MHG. Correction to: Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial. BMC Infect Dis. 2021 May 11; 21(1):436. PMID: 33975548.
      Citations: 1     Fields:    
    2. Alireza Hashemi S, Bahrani S, Mojtaba Mousavi S, Omidifar N, Ghaleh Golab Behbahan N, Arjmand M, Ramakrishna S, Bagheri Lankarani K, Moghadami M, Shokripour M, Firoozsani M, Chiang WH. Ultra-precise label-free nanosensor based on integrated graphene with Au nanostars toward direct detection of IgG antibodies of SARS-CoV-2 in blood. J Electroanal Chem (Lausanne). 2021 Aug 01; 894:115341. PMID: 33994897.
      Citations: 3     
    3. Ranjbar K, Moghadami M, Mirahmadizadeh A, Fallahi MJ, Khaloo V, Shahriarirad R, Erfani A, Khodamoradi Z, Gholampoor Saadi MH. Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial. BMC Infect Dis. 2021 04 10; 21(1):337. PMID: 33838657.
      Citations: 30     Fields:    Translation:Humans
    4. Emami A, Akbari A, Javanmardi F, Lotfi M, Moghadami M, Sharifi M, Bakhtiari H, Falahati F. Designing a Multicenter Registry of COVID-19 and Other Respiratory Infections in Fars, Iran. Disaster Med Public Health Prep. 2021 Apr 06; 1-4. PMID: 33820582.
      Citations: 1     Fields:    
    5. Sabetian G, Moghadami M, Hashemizadeh Fard Haghighi L, Shahriarirad R, Fallahi MJ, Asmarian N, Moeini YS. COVID-19 infection among healthcare workers: a cross-sectional study in southwest Iran. Virol J. 2021 03 17; 18(1):58. PMID: 33731169.
      Citations: 18     Fields:    Translation:Humans
    6. Mousavi SM, Hashemi SA, Parvin N, Gholami A, Ramakrishna S, Omidifar N, Moghadami M, Chiang WH, Mazraedoost S. Recent biotechnological approaches for treatment of novel COVID-19: from bench to clinical trial. Drug Metab Rev. 2021 02; 53(1):141-170. PMID: 33138652.
      Citations: 5     Fields:    Translation:Humans
    7. Sabayan B, Moghadami M, Assarzadegan F, Komachali SH, Poorsaadat L, Babaeepour Z, Ebrahimzadeh SA, Hamidi A, Hasheminejad ZS, Mohammadi-Vosough E, Mirkarimi HR, Paybast S, Rahimian N, Safari A, Sepehrnia M, Nematollahi R, Shahripour RB, Batra A, Sorond F, Borhani-Haghighi A. COVID-19 Respiratory Illness and Subsequent Cerebrovascular Events, the Initial Iranian Experience. J Stroke Cerebrovasc Dis. 2021 Jan; 30(1):105454. PMID: 33212340.
      Citations: 6     Fields:    Translation:Humans
    8. Hashemi SA, Golab Behbahan NG, Bahrani S, Mousavi SM, Gholami A, Ramakrishna S, Firoozsani M, Moghadami M, Lankarani KB, Omidifar N. Ultra-sensitive viral glycoprotein detection NanoSystem toward accurate tracing SARS-CoV-2 in biological/non-biological media. Biosens Bioelectron. 2021 Jan 01; 171:112731. PMID: 33075725.
      Citations: 17     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    9. Sefidbakht S, Lotfi M, Moghadami M, Jalli R, Shakibafard A, Iranpour P, Jafari SH, Bijan B. Recommendations on COVID-19 Computerized Tomography Study Reporting: The Need to Optimize Reporting Categories Based on Local Conditions and Available Resources. Iran J Med Sci. 2020 Jul; 45(4):313-315. PMID: 32801422.
      Citations: 1     
    10. Asadi-Pooya AA, Attar A, Moghadami M, Karimzadeh I. Management of COVID-19 in people with epilepsy: drug considerations. Neurol Sci. 2020 Aug; 41(8):2005-2011. PMID: 32594268.
      Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
    11. Shahriarirad R, Khodamoradi Z, Erfani A, Hosseinpour H, Ranjbar K, Emami Y, Mirahmadizadeh A, Lotfi M, Shirazi Yeganeh B, Dorrani Nejad A, Hemmati A, Ebrahimi M, Moghadami M. Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran. BMC Infect Dis. 2020 Jun 18; 20(1):427. PMID: 32552751.
      Citations: 50     Fields:    Translation:HumansCellsPHPublic Health
    12. Emami A, Javanmardi F, Akbari A, Moghadami M, Bakhtiari H, Falahati F, Hashemi Zadeh Fard Haghighi L, Rezaei T. Characteristics of deceased patients with CoVID-19 after the first peak of the epidemic in Fars province, Iran. Infect Ecol Epidemiol. 2020 Jun 17; 10(1):1781330. PMID: 32944160.
      Citations: 4     
    13. Habibzadeh P, Moghadami M, Lankarani KB. The effect of potential therapeutic agents on QT interval in patients with COVID-19 Infection: The importance of close monitoring and correction of electrolytes. Med Hypotheses. 2020 10; 143:109847. PMID: 32460209.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    14. Sefidbakht S, Lotfi M, Jalli R, Moghadami M, Sabetian G, Iranpour P. Methanol toxicity outbreak: when fear of COVID-19 goes viral. Emerg Med J. 2020 Jul; 37(7):416. PMID: 32414710.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    15. Tabari P, Amini M, Moghadami M, Moosavi M. International Public Health Responses to COVID-19 Outbreak: A Rapid Review. Iran J Med Sci. 2020 May; 45(3):157-169. PMID: 32546882.
      Citations: 20     
    16. Khodamoradi Z, Moghadami M, Lotfi M. Co-infection of Coronavirus Disease 2019 and Influenza A: A Report from Iran. Arch Iran Med. 2020 Apr 01; 23(4):239-243. PMID: 32271596.
      Citations: 32     Fields:    Translation:HumansCellsPHPublic Health
    Moghadami's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (118)
    Explore
    _
    Co-Authors (78)
    Explore
    _
    Similar People (60)
    Explore
    _